EUPHORBIA

OTHER NAME(S):

Asthmaplant, Chamaesyce hirta, Euforbia, Euphorbe, Euphorbia hirta, Euphorbia capitulata, Euphorbia pilulifera, Euphorbium Officinarum, Pillbearing Spurge, Snakeweed.<br/><br/>

Overview

Overview Information

Euphorbia is an herb. The parts of the plant that grow above the ground are used to make medicine.

Euphorbia is used for breathing disorders including asthma, bronchitis, and chest congestion. It is also used for mucus in the nose and throat, throat spasms, hay fever, and tumors. Some people use it to cause vomiting.

In India, it is also used for treating worms, severe diarrhea (dysentery), gonorrhea, and digestive problems.

How does it work?

Some researchers have studied how euphorbia might work in animals, but there isn't enough information to know how euphorbia might work in people.

Uses

Uses & Effectiveness?

Insufficient Evidence for

More evidence is needed to rate the effectiveness of euphorbia for these uses.

Side Effects

Side Effects & Safety

There isn't enough information available to know if euphorbia is safe.

When taken by mouth, it can cause some side effects such as nausea and vomiting.

Don’t touch the fresh herb. It can cause skin irritation or allergic reactions.

Special Precautions & Warnings:

Pregnancy and breast-feeding: It is POSSIBLY UNSAFE to take euphorbia by mouth if you are pregnant. There is some evidence that it might cause the uterus to contract, and this could cause a miscarriage.

Stomach or intestinal problems: Euphorbia can irritate the stomach and intestines. Don’t use it if you have a stomach or intestinal disorder.

Interactions

Interactions?

We currently have no information for EUPHORBIA Interactions.

Dosing

Dosing

The appropriate dose of euphorbia depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for euphorbia. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

  • Agrawal, D. K., Chandra, J., and Raju, T. V. Clinical studies of Euphorbia acaulis, Rox b. in cases of eczema--a preliminary report. Indian J.Dermatol. 1971;16(3):57-59. View abstract.
  • Antcliff, R. J., Hodgkins, P. R., Bowman, R., and Keast-Butler, J. Euphorbia lathyris latex keratoconjunctivitis. Eye 1994;8 ( Pt 6):696-698. View abstract.
  • Bala, T. M. and Panda, M. No poinsettia this Christmas. South.Med J 2006;99(7):772-773. View abstract.
  • Bani, S., Kaul, A., Khan, B., Gupta, V. K., Satti, N. K., Suri, K. A., and Qazi, G. N. Anti-arthritic activity of a biopolymeric fraction from Euphorbia tirucalli. J Ethnopharmacol 3-1-2007;110(1):92-98. View abstract.
  • Biedner, B. Z., Sachs, U., and Witztum, A. Euphorbia peplus latex keratoconjunctivitis. Ann.Ophthalmol. 1981;13(6):739-740. View abstract.
  • Calnan, C. D. Petty spurge (Euphorbia peplus L.). Contact Dermatitis 1975;1(2):128. View abstract.
  • Cateni, F., Zilic, J., Falsone, G., Hollan, F., Frausin, F., and Scarcia, V. Preliminary biological assay on cerebroside mixture from Euphorbia nicaeensis All. Isolation and structure determination of five glucocerebrosides. Farmaco 2003;58(9):809-817. View abstract.
  • D'Arcy, W. G. Letter: Severe contact dermatitis from poinsettia. Arch Dermatol 1974;109(6):909-910. View abstract.
  • Duarte, N. and Ferreira, M. J. Lagaspholones A and B: two new jatropholane-type diterpenes from Euphorbia lagascae. Org Lett 2-1-2007;9(3):489-492. View abstract.
  • Dubovsky, H. Famous physicians-botanists. S.Afr.Med J 6-1-1985;67(22):901-905. View abstract.
  • Eberle, M. M., Erb, C., Flammer, J., and Meyer, P. [Dermatitis and conjunctivitis after contact with Euphorbia myrsinites (wolf's milk extract)--a case report]. Klin.Monatsbl.Augenheilkd. 1999;215(3):203-204. View abstract.
  • Edwards, N. Local toxicity from a poinsettia plant: a case report. J Pediatr 1983;102(3):404-405. View abstract.
  • Eke, T. Acute kerato-uveitis associated with topical self-administration of the sap of the Petty Spurge (Euphorbia peplus). Eye 1994;8 ( Pt 6):694-696. View abstract.
  • Eke, T. Euphorbia sap keratouveitis. Br.J.Ophthalmol. 1997;81(6):518. View abstract.
  • Eke, T., Al Husainy, S., and Raynor, M. K. The spectrum of ocular inflammation caused by euphorbia plant sap. Arch.Ophthalmol. 2000;118(1):13-16. View abstract.
  • Ferreira, M. J., Duarte, N., Gyemant, N., Radics, R., Cherepnev, G., Varga, A., and Molnar, J. Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells. Anticancer Res 2006;26(5A):3541-3546. View abstract.
  • Ghen, Y., Tang, Z. J., Jiang, F. X., Zhang, X. X., and Lao, A. N. [Studies on the active principles of Ze-Qi (Euphorbia helioscopia L.), a drug used for chronic bronchitis (I) (author's transl)]. Yao Xue.Xue.Bao. 1979;14(2):91-95. View abstract.
  • Haupt, H. [Toxic and less toxic plants. 35]. Kinderkrankenschwester. 1997;16(12):529. View abstract.
  • Hellerman, R. C. and Hazleton, L. W. The antispasmotic action of View abstract.
  • Hsueh, K. F., Lin, P. Y., Lee, S. M., and Hsieh, C. F. Ocular injuries from plant sap of genera Euphorbia and Dieffenbachia. J.Chin Med.Assoc. 2004;67(2):93-98. View abstract.
  • Ibanez, M. D., Fernandez-Nieto, M., Martinez, J., Cardona, G. A., Guisantes, J., Quirce, S., and Sastre, J. Asthma induced by latex from 'Christmas flower' (Euphorbia pulcherrima). Allergy 2004;59(10):1127-1128. View abstract.
  • Imai, S., Sugiura, M., Mizuno, F., Ohigashi, H., Koshimizu, K., Chiba, S., and Osato, T. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity. Anticancer Res. 1994;14(3A):933-936. View abstract.
  • Ito, Y., Kawanishi, M., Harayama, T., and Takabayashi, S. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Cancer Lett. 1981;12(3):175-180. View abstract.
  • Krenzelok, E. P., Jacobsen, T. D., and Aronis, J. M. Plant exposures: a state profile of the most common species. Vet.Hum.Toxicol. 1996;38(4):289-298. View abstract.
  • Lin, L. J., Marshall, G. T., and Kinghorn, A. D. The dermatitis-producing constituents of Euphorbia hermentiana latex. J.Nat.Prod. 1983;46(5):723-731. View abstract.
  • Liu, Y. X., Wang, M. Z., and Sun, X. F. [Clinical analysis of 72 epileptic patients treated with alkaline extract of Euphorbia fisheriana]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1994;14(5):282-4, 261. View abstract.
  • Lodhi, M. A., Hussain, J., Abbasi, M. A., Jassbi, A. R., Choudhary, M. I., and Ahmad, V. U. A new Bacillus pasteurii urease inhibitor from Euphorbia decipiens. J Enzyme Inhib.Med Chem 2006;21(5):531-535. View abstract.
  • Luo, H. and Wang, A. Induction of apoptosis in K562 cells by jolkinolide B. Can.J Physiol Pharmacol 2006;84(10):959-965. View abstract.
  • MacNeil, A., Sumba, O. P., Lutzke, M. L., Moormann, A., and Rochford, R. Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br.J.Cancer 5-19-2003;88(10):1566-1569. View abstract.
  • Massmanian, A. Contact dermatitis due to Euphorbia pulcherrima Willd, simulating a phototoxic reaction. Contact Dermatitis 1998;38(2):113-114. View abstract.
  • Miyata, S., Wang, L. Y., Yoshida, C., and Kitanaka, S. Inhibition of cellular proliferation by diterpenes, topoisomerase II inhibitor. Bioorg.Med.Chem 11-24-2005; View abstract.
  • Natarajan, D., Britto, S. J., Srinivasan, K., Nagamurugan, N., Mohanasundari, C., and Perumal, G. Anti-bacterial activity of Euphorbia fusiformis-A rare medicinal herb. J Ethnopharmacol. 10-31-2005;102(1):123-126. View abstract.
  • Ogbourne, S. M., Hampson, P., Lord, J. M., Parsons, P., De Witte, P. A., and Suhrbier, A. Proceedings of the First International Conference on PEP005. Anticancer Drugs 2007;18(3):357-362. View abstract.
  • Osato, T., Mizuno, F., Imai, S., Aya, T., Koizumi, S., Kinoshita, T., Tokuda, H., Ito, Y., Hirai, N., Hirota, M., and . African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet 5-30-1987;1(8544):1257-1258. View abstract.
  • Pigatto, P. D., Persichini, P., Kokelj, F., and Daris, F. A new case of pseudophytodermatitis: allergic contact dermatitis from nickel in an ornamental plant (Euphorbia triangularis). Contact Dermatitis 2002;46(6):354. View abstract.
  • Pinedo, J. M., Saavedra, V., Gonzalez-de-Canales, F., and Llamas, P. Irritant dermatitis due to Euphorbia marginata. Contact Dermatitis 1985;13(1):44. View abstract.
  • Rau, O., Wurglics, M., Dingermann, T., Abdel-Tawab, M., and Schubert-Zsilavecz, M. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie 2006;61(11):952-956. View abstract.
  • Ruan, H. L., Zhou, X. F., Zhang, Y. H., Pi, H. F., Wu, J. Z., and Sun, H. D. Ferulic acid esters from Euphorbia hylonoma. Fitoterapia 2007;78(1):72-73. View abstract.
  • Samokhval, G. T. and Krivchak, G. G. [Dermatitis caused by a decorative plant, Euphorbia variegata]. Vestn.Dermatol.Venerol. 1974;48(3):85-86. View abstract.
  • Santucci, B., Picardo, M., and Cristaudo, A. Contact dermatitis from Euphorbia pulcherrima. Contact Dermatitis 1985;12(5):285-286. View abstract.
  • Scott, I. U. and Karp, C. L. Euphorbia sap keratopathy: four cases and a possible pathogenic mechanism. Br.J.Ophthalmol. 1996;80(9):823-826. View abstract.
  • Shi, X. H., Du, X. L., and Kong, L. Y. [Studies on chemical constituents in roots of Euphorbia soongarica]. Zhongguo Zhong.Yao Za Zhi. 2006;31(18):1503-1506. View abstract.
  • Silva, A. C., de Faria, D. E., Borges, N. B., de Souza, I. A., Peters, V. M., and Guerra, Mde O. Toxicological screening of Euphorbia tirucalli L.: developmental toxicity studies in rats. J Ethnopharmacol 3-1-2007;110(1):154-159. View abstract.
  • Singla, A. K. and Pathak, K. Anti-inflammatory studies on Euphorbia prostrata. J Ethnopharmacol. 1989;27(1-2):55-61. View abstract.
  • Smirnov, L. D. and Efremov, A. I. [Dermatitis due to Euphorbia rigida M.B]. Vestn.Dermatol.Venerol. 1970;44(6):67-69. View abstract.
  • Sofat, B. K., Sood, G. C., Chandel, R. D., and Mehrotra, S. K. Euphorbia royleana latex keratitis. Am.J.Ophthalmol. 1972;74(4):634-637. View abstract.
  • Sood, G. C., Sofat, B. K., and Chandel, R. D. Injury to the eye by the sap of Euphorbia royleana. Br.J.Ophthalmol. 1971;55(12):856-857. View abstract.
  • Spoerke, D. G. and Temple, A. R. Dermatitis after exposure to a garden plant (Euphorbia myrsinites). Am.J.Dis.Child 1979;133(1):28-29. View abstract.
  • Staib, F., Folkens, U., Tompak, B., Abel, T., and Thiel, D. A comparative study of antigens of Aspergillus fumigatus isolates from patients and soil of ornamental plants in the immunodiffusion test. Zentralbl.Bakteriol.[Orig.A] 1978;242(1):93-99. View abstract.
  • Szafran, L. [Acute conjunctivitis and keratitis due to the sap of Euphorbia marginata]. Pol.Tyg.Lek. 5-1-1967;22(18):671-672. View abstract.
  • Urushibata, O. and Kase, K. Irritant contact dermatitis from Euphorbia marginata. Contact Dermatitis 1991;24(2):155-156. View abstract.
  • Valadares, M. C., Carrucha, S. G., Accorsi, W., and Queiroz, M. L. Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumour-bearing mice. Int.Immunopharmacol. 2006;6(2):294-299. View abstract.
  • Valente, C., Ferreira, M. J., Abreu, P. M., Pedro, M., Cerqueira, F., and Nascimento, M. S. Three new jatrophane-type diterpenes from Euphorbia pubescens. Planta Med. 2003;69(4):361-366. View abstract.
  • Worobec, S. M., Hickey, T. A., Kinghorn, A. D., Soejarto, D. D., and West, D. Irritant contact dermatitis from an ornamental Euphorbia. Contact Dermatitis 1981;7(1):19-22. View abstract.
  • Yam, A. A., Gaye, F., Dieme, F. A., Bassene, E., and Ba, I. [Application of phytotherapy in odontology: the case of Euphorbia balsamifera. Endodontic clinical trial]. Dakar Med. 1997;42(2):169-171. View abstract.
  • Yin, Z. Q., Fan, C. L., Ye, W. C., Jiang, R. W., Che, C. T., Mak, T. C., Zhao, S. X., and Yao, X. S. Acetophenone derivatives and sesquiterpene from Euphorbia ebracteolata. Planta Med. 2005;71(10):979-982. View abstract.
  • Yu, F. R., Lian, X. Z., Guo, H. Y., McGuire, P. M., Li, R. D., Wang, R., and Yu, F. H. Isolation and characterization of methyl esters and derivatives from Euphorbia kansui (Euphorbiaceae) and their inhibitory effects on the human SGC-7901 cells. J Pharm.Pharm.Sci. 2005;8(3):528-535. View abstract.
  • Yu, F., Lu, S., Yu, F., Feng, S., McGuire, P. M., Li, R., and Wang, R. Protective effects of polysaccharide from Euphorbia kansui (Euphorbiaceae) on the swimming exercise-induced oxidative stress in mice. Can.J Physiol Pharmacol 2006;84(10):1071-1079. View abstract.
  • Zhang, X., Wang, H., Sheng, J., and Luo, X. A new guaiane diterpenoid from Euphorbia wallichii. Nat Prod.Res 2006;20(1):89-92. View abstract.
  • Feizbakhsh, A., Bighdeli, M., Tehrani, M. S., Rustaiyan, A., and Masoudi, S. Chemical constituents of the essential oil of Euphorbia teheranica Boiss., a species endemic to Iran. J Essent Oil Res. 2004;16(1):40-41.
  • Paulsen, E., Skov, P. S., and Andersen, K. E. Immediate skin and mucosal symptoms from pot plants and vegetables in gardeners and greenhouse workers. Contact Dermatitis 1998;39(4):166-170. View abstract.

Vitamins Survey

Have you ever purchased EUPHORBIA?

Did you or will you purchase this product in-store or online?

Where did you or where do you plan to purchase this product?

Where did you or where do you plan to purchase this product?

What factors influenced or will influence your purchase? (check all that apply)

Vitamins Survey

Where did you or where do you plan to purchase this product?

Do you buy vitamins online or instore?

What factors are most important to you? (check all that apply)

More Resources for EUPHORBIA

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.